AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30084882
Drug: Protease inhibitor
RxNorm normalized name: Protease inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitor monotherapy (PIM)
Trial: 11090583
Drug: Head-down tilt
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Head-down tilt during Exercise treatment (15 min cycling at 70% maximal O2 uptake)
Trial: 11090583
Drug: Head-up tilt
RxNorm normalized name: Head & Shoulders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Head-up tilt during Exercise treatment
Trial: 11090583
Drug: Head-up tilt
RxNorm normalized name: Head & Shoulders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Head-up tilt during No-Exercise treatment (30 min resting)
Trial: 11090583
Drug: Head-down tilt
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Head-down tilt during No-Exercise treatment
Trial: 8476620
Drug: Thiopental 5
RxNorm normalized name: thiopental 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 5 mg/kg (Group 1)
Trial: 8476620
Drug: Ketamine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1.5 mg/kg (Group 2)
Trial: 8476620
Drug: Thiopental 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 3 mg/kg plus fentanyl 4 to 6 micrograms/kg (Group 3)
Trial: 8476620
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg/kg plus fentanyl 4 to 6 micrograms/kg (Group 4)
Trial: 3510638
Drug: Cefazolin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (2 g every four hours for four doses)
Trial: 3510638
Drug: Moxalactam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxalactam (2 g every four hours for four doses)
Trial: 29792554
Drug: Acetazolamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (250 mg three times a day)
Trial: 29792554
Drug: Methazolamide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methazolamide (100 mg twice a day)
Trial: 22710649
Drug: Azilsartan medoxomil/chlorthalidone
RxNorm normalized name: Azilsartan Medoxomil/Chlorthalidone 40 MG-25 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azilsartan medoxomil/chlorthalidone 40/25 mg
Trial: 22710649
Drug: Azilsartan medoxomil/chlorthalidone
RxNorm normalized name: Azilsartan Medoxomil/Chlorthalidone 40 MG-25 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azilsartan medoxomil/chlorthalidone 80/25 mg
Trial: 22114906
Drug: Olmesartan/hydrochlorothiazide 40/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/hydrochlorothiazide 40/25 mg
Trial: 10600919
Drug: Loxiglumide (CCK‐A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loxiglumide (CCK‐A receptor antagonist) with intraduodenal fat and preload of banana shake
Trial: 9428831
Drug: Acarbose (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (3 x 100 mg/day)
Trial: 29632615
Drug: Ranibizumab 0.5
RxNorm normalized name: RANIBIZUMAB 0.5MG/0.05ML INJ,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranibizumab 0.5 mg PRN
Trial: 27566855
Drug: Ranibizumab 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranibizumab 2.0 mg monthly (extra-large group, PEDs ≥352 μm)
Trial: 25061716
Drug: Formula supplemented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula supplemented with 8 g GOS/L (EF8)
Trial: 25061716
Drug: Formula supplemented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula supplemented with 4 g GOS/L (EF4)
Trial: 22143621
Drug: Low-energy-dense (LE)
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-energy-dense (LE) foods (30 kcal per 100 g)
Trial: 22143621
Drug: High-energy-dense (HE)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-energy-dense (HE) foods (130 kcal per 100 g)
Trial: 18410231
Drug: Moderately high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately high salt intake (11.2 g/d) with high calcium diet (1284 mg)
Trial: 18410231
Drug: Moderately low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately low calcium intake (518 mg)
Trial: 18410231
Drug: Moderately high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately high salt intake (11.2 g/d) with low calcium diet (518 mg)
Trial: 18410231
Drug: Moderately low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately low salt intake (3.9 g/d) with low calcium diet (518 mg)
Trial: 18410231
Drug: Moderately low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately low salt intake (3.9 g/d) with high calcium diet (1284 mg)
Trial: 2066644
Drug: Control (0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0.9% saline solution)
Trial: 11286044
Drug: Alprazolam (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (0.75 mg daily)
Trial: 1449200
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen of four (40 ml) or eight (80 ml) ampules of antivenom
Trial: 6731758
Drug: Inhalation anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation anesthesia with enflurane-nitrous oxide (EFL)
Trial: 21543992
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (prostaglandin analog)
Trial: 17878467
Drug: Bronchodilators (beta(2)-agonists
RxNorm normalized name: Bronchodil
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilators (beta(2)-agonists and anticholinergics), including once-a-day preparations and combination products with inhaled steroids.
Trial: 17878467
Drug: Anti-inflammatory agents
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-inflammatory agents under development for COPD.
Trial: 17878467
Drug: Smoking cessation
RxNorm normalized name: Zyban 150 MG Smoking Cessation 12 HR Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking cessation treatments.
Trial: 11907489
Drug: Topical administration
RxNorm normalized name: Octocaine 5 % Ointment for Oral and Topical Administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical administration of 0.1% 8-methoxypsoralen cream
Trial: 11907489
Drug: Topical administration
RxNorm normalized name: Octocaine 5 % Ointment for Oral and Topical Administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical administration of 3 mg/L 8-methoxypsoralen bath
Trial: 11907489
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of 0.6 or 1 mg/kg 8-methoxypsoralen
Trial: 7842186
Drug: Uniphyl (theophylline),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uniphyl (theophylline), once daily
Trial: 7842186
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (200 micrograms four times per day)
Trial: 7842186
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Uniphyl and salbutamol
Trial: 365289
Drug: Standard drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard drug treatment plus intermittent positive-pressure ventilation (IPPV)
Trial: 31050982
Drug: Extracorporeal Magnetic
RxNorm normalized name: MAGNESIA
DrugBank: Magnesium oxide (DB01377)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal Magnetic Innervation (ExMI) therapy
Trial: 29349982
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml physiological saline (Group A)
Trial: 29349982
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml tranexamic acid and 10 ml physiological saline (Group B)
Trial: 29349982
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml physiological saline (Group C)
Trial: 29349982
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml tranexamic acid and 10 ml physiological saline (Group D)
Trial: 26849923
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (Group A)
Trial: 26849923
Drug: Oral mycophenolate
RxNorm normalized name: mycophenolate
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral mycophenolate mofetil (MMF) (Group B)
Trial: 9500317
Drug: Low-dose cyclosporin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cyclosporin
Trial: 19566116
Drug: Standard-dose cyclosporin
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose cyclosporin
Trial: 12647600
Drug: Pravastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (40 mg/d; n = 5,170)
Trial: 10579150
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg with bupropion SR 300 mg (two 150 mg tablets)
Trial: 10579150
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 300 mg alone (two 150 mg tablets)
Trial: 1460158
Drug: Emotionally focused
RxNorm normalized name: AVOBENZONE 0.2 g in 1 g / BUTYLENE GLYCOL 0.1 g in 1 g TOPICAL CREAM [Focused Corrective]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emotionally focused therapy (EFT)
Trial: 1886157
Drug: Tamoxifen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen therapy (2 or 5 years)
Trial: 2189951
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no adjuvant endocrine therapy)
Trial: 6229567
Drug: 25% reduction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% reduction in lithium dosage
Trial: 6229567
Drug: 50% reduction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% reduction in lithium dosage
Trial: 6229567
Drug: Usual dose
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual dose of lithium (control)
Trial: 27084661
Drug: Proton Beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Beam Radiation Therapy
Trial: 25438482
Drug: NitroSense Derma
RxNorm normalized name: Derma Gran
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: NitroSense Derma Protect patch (24 mg, releasing 9 nmol/cm2/min of nitric oxide for 3 hours every other day for 3 weeks)
Trial: 25438482
Drug: NitroSense Derma
RxNorm normalized name: Derma Gran
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: NitroSense Derma Protect patch
Trial: 22097612
Drug: Entecavir 1.0
RxNorm normalized name: ENTECAVIR 1.0 mg ORAL TABLET, FILM COATED [BARACLUDE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entecavir 1.0 mg/d
Trial: 17615018
Drug: Intervention Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention Group (IG) - Brief intervention by dental professionals providing feedback on oral symptoms and dental treatments relevant to smoking.
Trial: 11956262
Drug: Oxaliplatin 60
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin 60 mg/m² on days 1, 8, and 15 repeated every 4 weeks (group 1; n = 16)
Trial: 11956262
Drug: Oxaliplatin 130
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin 130 mg/m² on days 1 and 15 of a 4-week cycle (group 2; n = 16)
Trial: 11956262
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment with oxaliplatin
Trial: 10450425
Drug: Chemoprophylaxis alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoprophylaxis alone or in combination with iron
Trial: 28625512
Drug: Higher-dose edoxaban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-dose edoxaban regimen (HDER)
Trial: 28625512
Drug: Lower-dose edoxaban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower-dose edoxaban regimen (LDER)
Trial: 31687762
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (HDER, LDER, Warfarin)
Trial: 28597176
Drug: Intervention Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention Group (IG) - Pharmacist monitoring with CARAT questionnaire every 2 weeks and counselling on disease management, ICS adherence, and inhalation technique
Trial: 22987022
Drug: Atomoxetine 80
RxNorm normalized name: atomoxetine 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 80 mg
Trial: 19573556
Drug: Aged garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged garlic extract (250 mg) plus Vitamin B12 (100 microg), folic acid (300 microg), Vitamin B6 (12.5 mg) and l‐arginine (100 mg) daily for 1 year
Trial: 7957512
Drug: M(r) 2264
RxNorm normalized name: M
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M(r) 2264 Cl 2 x 5 mg i.v.
Trial: 7957512
Drug: Morphine 2
RxNorm normalized name: apomorphine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 2 x 10 mg i.v.
Trial: 3054373
Drug: Induction chemotherapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy, surgery, postoperative radiotherapy
Trial: 3054373
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (surgery and postoperative radiotherapy)
Trial: 22182309
Drug: Combination group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination group (all extra contacts)
Trial: 24002499
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antiviral treatment)
Trial: 9818712
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg fexofenadine HCl
Trial: 9818712
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg fexofenadine HCl
Trial: 9818712
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg fexofenadine HCl
Trial: 9818712
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg fexofenadine HCl
Trial: 7646652
Drug: Systemic flurbiprofen;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic flurbiprofen; appropriate doses not specified
Trial: 2575765
Drug: Cavain (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cavain (2 x 200 mg daily)
Trial: 30768
Drug: Lorazepam 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 3.0 mg b.i.d. for 4 weeks
Trial: 11557486
Drug: Ethambutol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethambutol (15 mg/kg of body weight) administered orally once daily to subjects with AIDS and healthy volunteers.
Trial: 29974725
Drug: Phytotherapic combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytotherapic combination of L-Methionine, Hibiscus sabdariffa, and Boswellia serrata (1 tablet in the morning and 1 tablet in the evening for 7 days)
Trial: 29974725
Drug: Short term
RxNorm normalized name: Short Term Oral Swab System KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short term antibiotic treatment according to international guidelines recommendations
Trial: 25620034
Drug: Breathing exercises
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breathing exercises with positive expiratory pressure (10-15 cmH2O), 30 slow deep breaths twice a day for 2 months
Trial: 22744417
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mATPase histochemistry and MHC immunohistochemistry
Trial: 17403707
Drug: Alfentanil doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil doses of 15, 30, 45 microg kg‐1
Trial: 7657272
Drug: 12-month treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-month treatment starting with 6 MU three times a week, decreasing dose based on serum ALT (Group A: 59 cases)
Trial: 7657272
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose of 3 MU three times a week for 12 months (Group B: 61 cases)
Trial: 7657272
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose of 6 MU three times a week for 6 months (Group C: 54 cases)
Trial: 2503945
Drug: Sublingual Nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual Nitroglycerin
Trial: 2503945
Drug: Sublingual Nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual Nifedipine
Trial: 178838
Drug: Mithramycin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mithramycin at a dose of 25 mug/kg/day for 21 days
Trial: 28333342
Drug: Faropenem (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Faropenem (600 mg) + Amoxicillin/Clavulanic acid (500/125 mg)
Trial: 28333342
Drug: Rifampicin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin (10 mg/kg)
Trial: 28333342
Drug: Rifampicin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin (10 mg/kg) + Faropenem (600 mg) + Amoxicillin/Clavulanic acid (500/125 mg)
Trial: 23862647
Drug: 120 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg/kg weekly intravenous alpha1-PI
Trial: 23862647
Drug: 60 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/kg weekly intravenous alpha1-PI
Trial: 12207105
Drug: Computer-guided behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-guided behaviour therapy (BT)
Trial: 12207105
Drug: Clinician-guided behaviour
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinician-guided behaviour therapy (BT)
Trial: 10483277
Drug: Palliative accelerated
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palliative accelerated irradiation (PAIR) with a total dose of 32 Gy (2 x 2 Gy/d)
Trial: 10483277
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with a total dose of 60 Gy (K60)
Trial: 10483277
Drug: Both therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both therapies (PAIR and conventional)
Trial: 8552931
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg sustained-release melatonin
Trial: 8552931
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg fast-release melatonin
Trial: 8552931
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg sustained-release melatonin (2-month treatment)
Trial: 1793876
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg aspirin per day
Trial: 1793876
Drug: No aspirin
RxNorm normalized name: XS No Aspirin PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No aspirin or antiplatelet agents
Trial: 7011010
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plus six cycles of adjuvant chemotherapy
Trial: 7011010
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy alone or radiation therapy plus chemotherapy
Trial: 29209867
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) applied at 780 nm, masseter and temporal=5 J/cm2 (20 mW-0.5 W/cm2), TMJ area=7.5 J/cm2 (30 mW-0.8 W/cm2), eight sessions, twice a week.
Trial: 11800440
Drug: Without treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Without treatment (WT)
Trial: 29209867
Drug: Women with
RxNorm normalized name: Arthricare for Women Moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Women with low levels of anxiety, salivary cortisol below 10 ng/ml, and with contraceptive use
Trial: 26471311
Drug: 100,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100,000 IU oral D3 supplementation
Trial: 19083662
Drug: Spray and
RxNorm normalized name: Spray and Stretch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray and stretch treatment (vapocoolant blend of pentafluoropropane and tetrafluoroethane)
Trial: 19083662
Drug: Spray and
RxNorm normalized name: Spray and Stretch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray and stretch treatment